SARAJEVO (Bosnia and Herzegovina), May 13 (SeeNews) – Bosnian drug maker Bosnalijek [SAJ:BSNLR] said its net profit tripled to 2.4 million marka ($1.4 million/1.2 million euro) in the first three months of 2016, from 811,200 marka a year earlier.
Operating revenues increased 2.9% on the year to 23.2 million marka in the first quarter of 2016, while operating costs edged up 1.4% to 21.3 million marka, the company said in a financial report on Thursday.
In 2015 Bosnalijek's net profit amounted to 11.2 million marka, as operating revenue jumped 6% on the year to 126.9 million marka.
(1 euro=1.95583 Bosnian marka)